Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 120.45
+3.80 (3.26%)
At close: Sep 25, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 66 billion as of September 25, 2026. Its market cap has increased by 137.20% in one year.
Market Cap
66.00B
Enterprise Value
67.17B
Revenue
19.51B
Ranking
n/a
PE Ratio
47.22
Stock Price
120.45
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 66.00B, an increase of 662.31%. That is a compound annual growth rate of 7.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 66.00B | 193.28% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 164.72B |
| Viyash Scientific | 107.39B |
| Procter & Gamble Health | 90.03B |
| Bliss GVS Pharma | 72.89B |
| Sanofi India | 72.43B |
| FDC Limited | 56.27B |
| Novartis India | 48.65B |
| Gufic Biosciences | 42.24B |